Julie A. Jacob is a healthcare writer and with core interests in business, technology and insurance issues. She has served as a staff writer for both the American Medical News and JAMA. Her freelance articles on healthcare and other topics have appeared in ACEP News, BMJ, Chicago Tribune, HealthBiz Decoded, Health Data Management, Racine Journal Times and other publications.
In a study published in JAMA, researchers at UCSF used an innovative protein measurement assay developed by healthcare technology company SomaLogic to detect 1,130 different proteins in the plasma of nearly 2,000 individuals already diagnosed with coronary heart disease.
The goal of this new initiative is to make it easier for oncologists to have their patients tested for genetic mutations linked to cancer.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Engineering researchers at the University of Michigan have developed a battery-operated injectable computer with a radio antenna that can transmit data to a device located up to 12 inches outside of the body.
The Biosimilars Forum’s senior policy advisor, Michael Werner — who is also a partner at the law firm of Holland and Knight — talked with MedCity News about what’s going on with biosimilars.
“We showed that cancer stem cells co-opt an RNA editing system to clone themselves. What’s more, we found a method to dial it down,” said principal investigator Dr. Catriona Jamieson, of UC San Diego School of Medicine.
“There is a real need to detect cancers that are small [less than 1 cm] before they metastasize. That would be the Holy Grail.”
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
The network enables comprising 79 hospitals in 11 states to share anonymous cancer patient genomic data.
A forthcoming app is a sort of Tinder for clinical trial enrollment, so that patients can quickly find clinical trials in their geographic area matching their health interests and needs.
The videos are not peer-reviewed before posting. Instead, GIBLIB is relying on the collective wisdom of physicians to determine which videos to prominently feature.
“Computer algorithms facilitate doing the right thing,” said Dr. Joseph A. Aloi, professor of endocrinology and metabolism at Wake Forest Baptist Medical Center in Winston-Salem, North Carolina.
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.